Can We Outrun Cancer's Evolution? Why BrYet Is Targeting Cancer-Specific Phenotypes

Targeting genomic instability: From chemotherapy to precision medicine in cancer treatment

This article examines genomic instability as a hallmark of cancer, explaining how it drives malignant transformation through accumulated gen

Why every cancer is unique: Evolution, drug resistance, and the need for personalized treatments

This article explains cancer as an evolutionary disease, where genetic mutations and natural selection drive cancer development and drug res

A hidden weakness in deadly cancers could lead to powerful new treatments

A hidden weakness in deadly cancers could lead to powerful new treatments

Why a cancer researcher with a high genetic risk wants AI development to slow down

A personal essay from someone with a high genetic cancer risk who has spent years working toward AI-driven cancer detection. Despite persona

Why a cancer researcher with a high genetic risk wants AI development to slow down

A personal essay from someone with a high genetic cancer risk who has spent years working toward AI-driven cancer detection. Despite persona

Integrating multi-layer intratumor heterogeneity analysis to advance cancer immunotherapy

This article examines intratumor heterogeneity (ITH) as a multidimensional problem in cancer biology. It discusses how tumors consist of div

Living with a 100% cancer risk: One woman's story of a rare TP53 gene mutation

Tracy Hutchinson shares her personal story of living with a rare TP53 gene variant that gives her a 100% chance of developing cancer. After